Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.

Saved in:

Bibliographic Details
Title:	Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
Authors:	Trabelsi MS; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Daoudi M; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Prawitt J; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Ducastel S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Touche V; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Sayin SI; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden., Perino A; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland., Brighton CA; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Sebti Y; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Kluza J; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France., Briand O; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Dehondt H; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Vallez E; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Dorchies E; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Baud G; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Spinelli V; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Hennuyer N; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Caron S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Bantubungi K; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Caiazzo R; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Reimann F; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Marchetti P; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France., Lefebvre P; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Bäckhed F; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.; Section for Metabolic Receptology and Enteroendocrinology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen 2200, Denmark., Gribble FM; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Schoonjans K; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland., Pattou F; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Tailleux A; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Staels B; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Lestavel S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.
Source:	Nature communications [Nat Commun] 2015 Jul 02; Vol. 6, pp. 7629. Date of Electronic Publication: 2015 Jul 02.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database:	MEDLINE Ultimate

Be the first to leave a comment!